Literature DB >> 16157740

Double-blind, placebo-controlled trials for surgical interventions in Parkinson disease.

C Warren Olanow.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16157740     DOI： 10.1001/archneur.62.9.1343

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  4 in total

1.  A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).

Authors:  Roger K Cady; Peter J McAllister; Egilius L H Spierings; John Messina; Jennifer Carothers; Per G Djupesland; Ramy A Mahmoud
Journal:  Headache       Date:  2014-10-30       Impact factor: 5.887

2.  Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.

Authors:  Alan Whone; Matthias Luz; Mihaela Boca; Max Woolley; Lucy Mooney; Sonali Dharia; Jack Broadfoot; David Cronin; Christian Schroers; Neil U Barua; Lara Longpre; C Lynn Barclay; Chris Boiko; Greg A Johnson; H Christian Fibiger; Rob Harrison; Owen Lewis; Gemma Pritchard; Mike Howell; Charlie Irving; David Johnson; Suk Kinch; Christopher Marshall; Andrew D Lawrence; Stephan Blinder; Vesna Sossi; A Jon Stoessl; Paul Skinner; Erich Mohr; Steven S Gill
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

Review 3.  Feasibility of surgical randomised controlled trials with a placebo arm: a systematic review.

Authors:  Karolina Wartolowska; Gary S Collins; Sally Hopewell; Andrew Judge; Benjamin J F Dean; Ines Rombach; David J Beard; Andrew J Carr
Journal:  BMJ Open       Date:  2016-03-15       Impact factor: 2.692

4.  Computationally Developed Sham Stimulation Protocol for Multichannel Desynchronizing Stimulation.

Authors:  Magteld Zeitler; Peter A Tass
Journal:  Front Physiol       Date:  2018-05-08       Impact factor: 4.566
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.